Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Heart Test Laboratories WT (HSCSW)

Heart Test Laboratories WT (HSCSW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center GlobeNewswire - Thu Feb 5, 7:30AM CST

Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.    ( Nasdaq: HSCS; HSCSW ) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals GlobeNewswire - Thu Jan 29, 7:30AM CST

Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire - Mon Dec 15, 2025

Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device GlobeNewswire - Mon Dec 15, 2025

Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 GlobeNewswire - Thu Dec 11, 2025

Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results GlobeNewswire - Thu Sep 11, 2025

Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (“AI”)-powered medical technology company...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Announces Conference Participation and Investor Webinar GlobeNewswire - Fri Aug 15, 2025

Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (“AI”)-powered medical technology company...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results GlobeNewswire - Thu Jul 24, 2025

Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (“AI”)-powered medical technology company...

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis GlobeNewswire - Wed Jun 4, 2025

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value GlobeNewswire - Tue Jun 3, 2025

HSCSW : 0.1094 (+38.31%)
HSCS : 2.62 (-1.48%)

Barchart Exclusives

3 Top Dividend Stocks To Buy In March Barchart - Tue Mar 3, 6:30PM CST
With market volatility rising, these three dividend payers could anchor your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot